Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @_OpenPharma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @_OpenPharma
-
Prikvačeni tweet
What are the
#openscience challenges faced by authors in Japan? Check out this blog post from@ThinkSCIENCE to find out more!#openaccess#openforall#opensciencehttp://openpharma.blog/2020/02/05/guest-post-some-of-the-open-science-challenges-faced-by-authors-in-japan/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Calling all coronavirus researchers: keep sharing, stay openhttps://www.nature.com/articles/d41586-020-00307-x …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
The organization behind cOAlition S and Plan S seems to both exist and not existhttps://thegeyser.substack.com/p/is-the-s-for-schrdinger …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Researchers have scientific, ethical, and moral obligations to report the results of their research. Yet more than half of the results from clinical trials go unreported. Why? Find out more here.http://ow.ly/pNh450yeo9H
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
I am delighted that today we are announcing that newly submitted papers to
@nature will be published with peer review reports & authors' rebuttals upon their acceptance#peerreview#transparentreviewhttps://www.nature.com/articles/d41586-020-00309-9 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Debating the right
#enhancement for your#publication? Or, not sure about doing anything?#Videoabstract or#plainlanguagesummaries edge out#graphicalabstract and standard#abstract - apparently!#publications#journals#transparency#patientshttps://lnkd.in/f7eKnYdHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Does
#peerreview matter? Journals don't think enough of it to make their policies clear. The recent consensus on predatory journals concedes that "transparency in...how peer review [is] organized is presently somewhat aspirational in academic publishing. https://www.nature.com/articles/d41586-019-03759-y …https://twitter.com/RickyPo/status/1225044449237118977 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Looking to broaden the impact of your research? Consider writing a lay summary. Here are top tips to get you started!http://ow.ly/Ob2k50ydtDG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Would you like to get to know the most relevant Chinese research but do not know where to start?
@Science_Open featured and non-featured Collections are the right go-to resource! Click below for an overview: https://blog.scienceopen.com/2020/02/scienceopen-highlights-chinese-research-for-inclusive-open-science/ …pic.twitter.com/5V0Xnhc69C
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Trump pressed by Nobel laureates to make US-funded research available for free | News | Chemistry Worldhttps://ift.tt/3b4ORb3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Interesting to see
@Jisc@SHERPAServices plans for tracking Plan S (and UKRI) compliance options http://repository.jisc.ac.uk/7668/4/Sherpa_services_and_Plan_S_-_Adam_Field.pdf … https://twitter.com/lfvopenscience/status/1225064088230924288 …pic.twitter.com/GjmlU5MIDd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Interesting piece in
@NatureNews - do the algorithms we use to support research (e.g. grant and publisher peer reviewer selection) perpetuate bias?https://www.nature.com/articles/d41586-020-00274-3 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Really delighted to unveil some of the new business models we're exploring here!
#scholcomm#OAintheUS#beyondtheAPChttps://twitter.com/UKSG/status/1224646768425684992 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Society publishers are positive about transformative agreement models but concerned about the ability to access and negotiate directly with library consortia. Read more: https://onlinelibrary.wiley.com/doi/10.1002/leap.1272 …
@wisealic@lorraineestelle#openaccess@alpspHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
"As an ECR, it’s up to us to take the lead in thinking & communicating our research in the ways that we think are the most appropriate, &
@WellcomeOpenRes offers an opportunity to do so," says@BenSteventon2@SteventonLab,#ECRs advisory board member https://blog.wellcomeopenresearch.org/2020/02/04/the-research-community-should-move-beyond-the-constraints-of-traditional-peer-review/ …pic.twitter.com/IC9uGg5yGU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Great blog from Richard Stephens on why we need
#patientinvolvement Still lots to do but good to reflect on how far we've come.@HRA_Latesthttps://twitter.com/HRA_Latest/status/1224650268228407296 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je Tweet
Join us tomorrow (Feb 5) for week 3
@ReproducibiliT Journal Club at@OxPrimaryCare! We’ll be discussing “The#preregistration revolution” in@PNASNews by@BrianNosek@EvoMellor@CharlieEbersol https://www.pnas.org/content/115/11/2600 … All are welcome!@RR_Oxford@NDevito1pic.twitter.com/wsuUWuCe8M
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Open Pharma proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Open Pharma proslijedio/la je Tweet
Open Access Oxford: What's happening? - Oxford Talkshttps://ift.tt/393ZNDR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.